Biotechnology Analyst Boris Peaker Joins Cowen’s Equity Research Department

NEW YORK–(BUSINESS WIRE)–Jul. 14, 2014–
Cowen Group, Inc. (“Cowen”) (NASDAQ:COWN) today announced that Boris
Peaker
has joined Cowen and Company’s Equity Research department as a
Managing Director to cover Biotechnology stocks. Mr. Peaker is based in
New York and reports to Robert Fagin, Cowen’s Director of Research.

“We’re thrilled to welcome Boris back to Cowen, where he began his
equity research career,” said Mr. Fagin. “We look forward to adding
Boris’ insightful research product to our already preeminent biotech
platform, and to his collaboration with the rest of our health care
team.”

Mr. Peaker joins Cowen from Oppenheimer & Co., where he spent over three
years as a senior research analyst covering the biotechnology sector. He
previously held biotechnology equity research positions at Rodman &
Renshaw and at Cowen and Company. Mr. Peaker holds Bachelor of Science
degrees in Physics and in Chemistry, summa cum laude, from State
University of New York
at Stony Brook, and a Ph.D. in Biophysics from
Stanford University. He is a CFA® charterholder.

About Cowen Group, Inc.

Cowen Group, Inc. is a diversified financial services firm and, together
with its consolidated subsidiaries, provides alternative asset
management, investment banking, research, and sales and trading services
through its two business segments: Ramius and its affiliates make up the
Company’s alternative investment segment, while Cowen and Company and
its affiliates make up the Company’s broker-dealer segment. Ramius
provides alternative asset management solutions to a global client base
and manages a significant portion of Cowen’s proprietary capital. Cowen
and Company
and its affiliates offer industry focused investment banking
for growth-oriented companies, domain knowledge-driven research and a
sales and trading platform for institutional investors. Founded in 1918,
the firm is headquartered in New York and has offices worldwide.

Source: Cowen Group, Inc.

Media:
Sard Verbinnen & Co
Dan Gagnier/Carissa
Felger
212-687-8080

Press Inquiries

    If not, reach out to us directly for more information.